Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

BACKGROUND: Renal impairment is a common complication of multiple myeloma. Cystatin-C is considered an accurate marker of glomerular filtration rate in several renal disorders. Microarray analysis has revealed that cystatin-C is one of the most highly up-regulated genes in multiple myeloma. The aim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Terpos, Evangelos, Katodritou, Eirini, Tsiftsakis, Evangelos, Kastritis, Efstathios, Christoulas, Dimitrios, Pouli, Anastasia, Michalis, Eurydiki, Verrou, Evgenia, Anargyrou, Konstantinos, Tsionos, Konstantinos, Dimopoulos, Meletios A., Zervas, Konstantinos
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2009
Matèries:
Multiple Myeloma
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2649362/
https://ncbi.nlm.nih.gov/pubmed/19252175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2008.000638
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars